Finance Chiefs at Listed Nigerian Drugmakers Navigate Currency Pressures and Capital Costs
Finance executives at Nigeria’s top listed pharmaceutical companies are deploying defensive balance-sheet strategies to handle volatile foreign exchange rates, elevated borrowing costs, and rising input expenses.
